SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003298
Filing Date
2018-04-27
Accepted
2018-04-27 16:23:54
Documents
10
Period of Report
2018-06-12
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235506zdef14a.htm DEF 14A 711586
2 G701037.JPG g701037.jpg GRAPHIC 19481
3 G998358.JPG g998358.jpg GRAPHIC 15497
4 G971758.JPG g971758.jpg GRAPHIC 18907
5 G476244.JPG g476244.jpg GRAPHIC 57665
6 G614898.JPG g614898.jpg GRAPHIC 74283
7 G85154.JPG g85154.jpg GRAPHIC 9294
8 G571878.JPG g571878.jpg GRAPHIC 12765
9 G29862BGI001.GIF g29862bgi001.gif GRAPHIC 109135
10 G29862BGI002.GIF g29862bgi002.gif GRAPHIC 75019
  Complete submission text file 0001047469-18-003298.txt   1253866
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 18784267
SIC: 2834 Pharmaceutical Preparations